Phase I-II study of liposomal vincristine [Marqibo; Hana Biosciences] and dexamethasone in relapsed or refractory acute lymphoblastic leukemia
Phase of Trial: Phase I/II
Latest Information Update: 28 Nov 2013
At a glance
- Drugs Vincristine (Primary) ; Dexamethasone
- Indications Acute lymphoblastic leukaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Spectrum Pharmaceuticals
- 17 Jan 2012 Additional lead trial centre and investigator identified and company added as trial sponsor (Talon Therapeutics) as reported by ClinicalTrials.gov.
- 29 Nov 2010 According to a company media release, Hana Biosciences presented results from this and the RALLY trial at ASH (abstract A2143).
- 27 Jan 2009 Actual patient numbers added, as reported by ClinicalTrials.gov.